Skip to main content

Table 5 Global health status in maintenance therapy arms 1–3, and arms 2+3 versus control arm 5

From: A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study

Characteristic Arm 1
(n = 46)
Arm 2
(n = 76)
Arm 3
(n = 42)
Arms 2+3
(n = 118)
Arm 5
(n = 80)
At screening
 MS ± SD 77.51 ± 10.24 78.83 ± 10.35 76.97 ± 10.96 78.18 ± 10.56 78.24 ± 9.75
p* 0.6733 0.7162 0.5236 0.9690  
After combined treatment
 MS ± SD 63.51 ± 9.64 64.95 ± 8.65 63.52 ± 9.77 64.45 ± 9.04 63.98 ± 7.46
p* 0.7475 0.4603 0.7724 0.7085  
At the end of the study
 MS ± SD 55.37 ± 20.48 63.69 ± 14.88 58.23 ± 18.33 61.57 ± 16.41 53.19 ± 16.52
p* 0.6532 0.0060 0.2796 0.0240  
  1. MS mean score, SD standard deviation
  2. *Student’s test was applied to determine the differences between arms 1–3 vs arm 5 and arms 2+3 vs arm 5
  3. NOTE. Bold font indicates p < 0.05